Enovis(NYSE) ENOV

Enovis Corporation, formerly Colfax Corporation, is a medical technology company focused on delivering high-quality medical devices. These devices are mainly used in reconstructive surgery, rehabilitation, pain management, and physical therapy. The company's mission is to enhance patient outcomes and streamline healthcare workflows, particularly in orthopedic care. Enovis operates two main segments: Prevention & Recovery and Reconstructive, offering a broad spectrum of products that cater to various stages of patient care.

Products and Services

Orthopedic bracing and support products

Thermal and vascular therapy systems

Reconstructive joint implants and tools

Electric stimulators for pain management

Comprehensive physical therapy devices

What Makes Enovis Corporation Special

Enovis Corporation differentiates itself through its Enovis Growth eXcellence (EGX) business system, which drives continuous improvement. This system leverages clinical insights and advanced manufacturing techniques to enhance patient care and operational efficiency. Enovis's dedication to innovation and customer-centric support adds value for both patients and healthcare professionals.

Five Things You Need to Know

Enovis separated from its industrial business, ESAB, in 2022 to focus on medical technology.

The company operates in two segments: Prevention & Recovery and Reconstructive.

International operations generate approximately 41% of its sales, primarily from Europe.

Enovis continuously invests in research and development for new medical device innovations.

The company's main competitors include larger firms like Stryker and Zimmer Biomet, as well as niche companies.